Yamada Walter M, Neely Michael N, Bartroff Jay, Bayard David S, Burke James V, Guilder Mike van, Jelliffe Roger W, Kryshchenko Alona, Leary Robert, Tatarinova Tatiana, Schumitzky Alan
Laboratory of Applied Pharmacokinetics and Bioinformatics, Children's Hospital of Los Angeles, Los Angeles, CA 90027, USA.
Pediatric Infectious Diseases, Children's Hospital of Los Angeles, Keck School of Medicine, University of Southern California, Los Angeles, CA 90027, USA.
Pharmaceutics. 2020 Dec 30;13(1):42. doi: 10.3390/pharmaceutics13010042.
Population pharmacokinetic (PK) modeling has become a cornerstone of drug development and optimal patient dosing. This approach offers great benefits for datasets with sparse sampling, such as in pediatric patients, and can describe between-patient variability. While most current algorithms assume normal or log-normal distributions for PK parameters, we present a mathematically consistent nonparametric maximum likelihood (NPML) method for estimating multivariate mixing distributions without any assumption about the shape of the distribution. This approach can handle distributions with any shape for all PK parameters. It is shown in convexity theory that the NPML estimator is discrete, meaning that it has finite number of points with nonzero probability. In fact, there are at most points where is the number of observed subjects. The original infinite NPML problem then becomes the finite dimensional problem of finding the location and probability of the support points. In the simplest case, each point essentially represents the set of PK parameters for one patient. The probability of the points is found by a primal-dual interior-point method; the location of the support points is found by an adaptive grid method. Our method is able to handle high-dimensional and complex multivariate mixture models. An important application is discussed for the problem of population pharmacokinetics and a nontrivial example is treated. Our algorithm has been successfully applied in hundreds of published pharmacometric studies. In addition to population pharmacokinetics, this research also applies to empirical Bayes estimation and many other areas of applied mathematics. Thereby, this approach presents an important addition to the pharmacometric toolbox for drug development and optimal patient dosing.
群体药代动力学(PK)建模已成为药物研发和患者最佳给药的基石。这种方法对于稀疏采样的数据集(如儿科患者的数据)具有很大优势,并且能够描述患者间的变异性。虽然当前大多数算法假定PK参数呈正态或对数正态分布,但我们提出了一种数学上一致的非参数最大似然(NPML)方法,用于估计多元混合分布,而无需对分布形状做任何假设。这种方法可以处理所有PK参数的任何形状的分布。凸性理论表明NPML估计器是离散的,这意味着它具有有限数量的非零概率点。实际上,最多有个点,其中是观察对象的数量。那么原来的无限NPML问题就变成了寻找支撑点的位置和概率的有限维问题。在最简单的情况下,每个点本质上代表一个患者的PK参数集。点的概率通过原始对偶内点法找到;支撑点的位置通过自适应网格法找到。我们的方法能够处理高维和复杂的多元混合模型。讨论了群体药代动力学问题的一个重要应用,并处理了一个实际例子。我们的算法已成功应用于数百项已发表的药代动力学研究中。除了群体药代动力学,这项研究还适用于经验贝叶斯估计和应用数学的许多其他领域。因此,这种方法为药物研发和患者最佳给药的药代动力学工具箱增添了重要内容。